1. Home
  2. TCBK vs AGIO Comparison

TCBK vs AGIO Comparison

Compare TCBK & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCBK
  • AGIO
  • Stock Information
  • Founded
  • TCBK 1975
  • AGIO 2007
  • Country
  • TCBK United States
  • AGIO United States
  • Employees
  • TCBK N/A
  • AGIO N/A
  • Industry
  • TCBK Major Banks
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCBK Finance
  • AGIO Health Care
  • Exchange
  • TCBK Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • TCBK 1.2B
  • AGIO 1.4B
  • IPO Year
  • TCBK N/A
  • AGIO 2013
  • Fundamental
  • Price
  • TCBK $38.88
  • AGIO $28.37
  • Analyst Decision
  • TCBK Hold
  • AGIO Buy
  • Analyst Count
  • TCBK 5
  • AGIO 8
  • Target Price
  • TCBK $50.75
  • AGIO $56.57
  • AVG Volume (30 Days)
  • TCBK 136.2K
  • AGIO 684.6K
  • Earning Date
  • TCBK 04-28-2025
  • AGIO 05-01-2025
  • Dividend Yield
  • TCBK 3.41%
  • AGIO N/A
  • EPS Growth
  • TCBK N/A
  • AGIO N/A
  • EPS
  • TCBK 3.46
  • AGIO 11.64
  • Revenue
  • TCBK $389,190,000.00
  • AGIO $36,498,000.00
  • Revenue This Year
  • TCBK $7.94
  • AGIO $41.13
  • Revenue Next Year
  • TCBK $5.64
  • AGIO $234.96
  • P/E Ratio
  • TCBK $11.18
  • AGIO $2.45
  • Revenue Growth
  • TCBK N/A
  • AGIO 36.07
  • 52 Week Low
  • TCBK $33.35
  • AGIO $23.42
  • 52 Week High
  • TCBK $51.06
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • TCBK 52.19
  • AGIO 48.67
  • Support Level
  • TCBK $36.26
  • AGIO $26.92
  • Resistance Level
  • TCBK $37.34
  • AGIO $28.38
  • Average True Range (ATR)
  • TCBK 1.86
  • AGIO 1.70
  • MACD
  • TCBK 0.32
  • AGIO 0.37
  • Stochastic Oscillator
  • TCBK 83.07
  • AGIO 85.79

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: